Safety Shot, Inc. (SHOT)
NASDAQ: SHOT · Real-Time Price · USD
1.040
+0.053 (5.39%)
At close: Nov 1, 2024, 4:00 PM
1.020
-0.020 (-1.92%)
After-hours: Nov 1, 2024, 6:46 PM EDT
Company Description
Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property.
The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content.
It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.
The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023.
Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Safety Shot, Inc.
Country | United States |
Founded | 2018 |
IPO Date | Oct 30, 2020 |
Industry | Beverages - Non-Alcoholic |
Sector | Consumer Staples |
Employees | 8 |
CEO | Jarrett Boon |
Contact Details
Address: 1061 East Indiantown Road, Suite 110 Jupiter, Florida 33477 United States | |
Phone | 561 244 7100 |
Website | safetyshotofficial.com |
Stock Details
Ticker Symbol | SHOT |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $7.50 |
CIK Code | 0001760903 |
ISIN Number | US48208F1057 |
Employer ID | 83-2455880 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Jarrett A. Boon | Chief Executive Officer and Director |
Jordan Schur | President and Director |
Danielle De Rosa-Diaz | Chief Financial Officer |
Anthony Pedicelli | Director of Marketing |
Dr. Andy Goren M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
Josh Wagner | Chief Revenue Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 1, 2024 | 8-K | Current Report |
Oct 29, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
Oct 17, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
Oct 11, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
Oct 9, 2024 | 8-K | Current Report |
Sep 30, 2024 | 8-K | Current Report |
Sep 26, 2024 | 8-K | Current Report |
Sep 24, 2024 | S-3 | Registration statement under Securities Act of 1933 |
Sep 24, 2024 | 8-K | Current Report |
Sep 19, 2024 | 8-K | Current Report |